Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Genetically modified (GM) maize MON 94804 was developed to achieve a reduction in plant height by introducing the suppression cassette. The molecular characterisation and bioinformatic analyses do not identify issues requiring food/feed safety assessment. None of the agronomic/phenotypic and compositional differences identified between maize MON 94804 and its conventional counterpart needs further assessment, except for ear height, plant height and levels of carbohydrates in forage, which do not raise safety or nutritional concerns. The Panel on Genetically Modified Organisms (GMO Panel) does not identify safety concerns regarding the toxicity and allergenicity of the GA20ox_SUP precursor-miRNA and derived mature miRNA as expressed in maize MON 94804 and finds no evidence that the genetic modification would change the overall allergenicity of maize MON 94804. In the context of this application, the consumption of food and feed from maize MON 94804 does not represent a nutritional concern in humans and animals. The GMO Panel concludes that maize MON 94804 is as safe as the conventional counterpart and non-GM maize varieties tested, and no post-market monitoring of food/feed is considered necessary. In the case of accidental release of viable maize MON 94804 grains into the environment, this would not raise environmental safety concerns. The post-market environmental monitoring plan and reporting intervals are in line with the intended uses of maize MON 94804. The GMO Panel concludes that maize MON 94804 is as safe as its conventional counterpart and the tested non-GM maize varieties with respect to potential effects on human and animal health and the environment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11046408PMC
http://dx.doi.org/10.2903/j.efsa.2024.8714DOI Listing

Publication Analysis

Top Keywords

maize mon
40
mon 94804
40
genetically modified
12
maize
12
conventional counterpart
12
gmo panel
12
mon
10
0
10
modified maize
8
plant height
8

Similar Publications

At the request of the European Commission, the European Food Safety Authority (EFSA) assessed the 2023 post-market environmental monitoring (PMEM) report on the cultivation of the genetically modified maize event MON 810, which expresses the Cry1Ab protein. The report provides no evidence of adverse effects from maize MON 810 cultivation. It confirms high refuge compliance among farmers in Spain and Portugal.

View Article and Find Full Text PDF

Over the past few decades, scientific interest in mycotoxins-fungal metabolites that pose serious concern to food safety, crop health, and both human and animal health-has increased. While major mycotoxins such as aflatoxins, ochratoxins, deoxynivalenol, fumonisins, zearalenone, citrinin, patulin, and ergot alkaloids are well studied, emerging mycotoxins remain underexplored and insufficiently investigated. Among these, moniliformin (MON) is frequently detected in maize-based food and feed; however, the absence of regulatory limits and standardized detection methods limits effective monitoring and comprehensive risk assessment.

View Article and Find Full Text PDF

HLDP nano-assembly boosts monosultap insecticidal activity against Asian corn borers through enhanced neurotoxicity and energy depletion.

Pestic Biochem Physiol

September 2025

State Key Laboratory of Agricultural and Forestry Biosecurity, MARA Key Lab of Surveillance and Management for Plant Quarantine Pests, College of Plant Protection, China Agricultural University, Beijing 100193, PR China. Electronic address:

The incorporation of nanotechnology presents an innovative strategy to overcome the limitations of conventional pesticides for efficient utilization. Herein, a hydrophilic and lipophilic diblock polymer (HLDP) nanocarrier was successfully synthesized and employed to encapsulate monosultap (Mon), yielding a highly-effective nanoformulation. HLDP exhibited a drug loading capacity of approximately 16.

View Article and Find Full Text PDF

Moniliformin (MON), a mycotoxin produced by species, has recently raised health concerns. Therefore, MON levels were determined in 399 cereal grain samples obtained from retail stores across Japan between April 2020 and July 2024. The survey showed the presence of MON in 36% of the tested samples.

View Article and Find Full Text PDF

Chitosan and technical cashew nutshell liquid (CNSLt) have emerged as promising natural compounds due to their antimicrobial, immunomodulatory, and fermentation-modulating properties. This study aimed to evaluate the inclusion of chitosan and CNSLt as potential substitutes for the ionophore monensin on feed intake, ruminal fermentation, nitrogen balance, and microbial protein synthesis in steers. Five crossbred steers (), 18 months old with an average body weight of approximately 350 kg and fitted with permanent ruminal cannulas, were assigned to a 5 × 5 Latin square design.

View Article and Find Full Text PDF